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Summary 
The  Src homology (SH)  2/SH3  domain-containing  protein  Grb2  and  the  oncoprotein  Shc 
have been implicated in a highly conserved mechanism that regulates p21 ras activation. We in- 
vestigated  the  involvement  of these  adaptor  proteins  in  the  signaling  pathway  induced  by 
CD16 or interleukin  (IL) 2R triggering in human natural killer (NK) cells. Both p46 and p52 
forms of Shc were rapidly and transiently tyrosine phosphorylated upon CD16 or IL-2 stimula- 
tion with different kinetics. Shc immunoprecipitates from lysates of CD 16- or IL-2~timulated 
NK ceils  contained Grb2 and an unidentified  145-kD tyrosine phosphoprotein.  Grb2 immu- 
noprecipitates from anti-CD16-stimulated NK cells contained not only Shc, but also a 36-kD 
tyrosine phosphoprotein (p36). The interaction between Grb2 and Shc or p36 occurred via the 
Grb2SH2 domain as indicated by in vitro binding assays using a bacteriologically synthesized 
glutathione S-transferase-Grb2SH2 fusion protein. We also present evidence that p21 ~  is acti- 
vated by CD16 and IL-2R cross-linking. Accumulation ofguanosine triphosphate-bound P,  as 
was detected within  1 minute and occurred with kinetics similar to inductive protein tyrosine 
phosphorylation and Grb2 association of Shc and p36 adaptor proteins. 
N 
'K ceils are a CD3-CD16+CD56 + subset oflympho- 
cytes that play a key role in nonadaptive immune re- 
sponse against microbial infections and tumor ceil growth. 
They lyse a  variety of target cells by direct cell-mediated 
cytotoxicity or in an Ab-dependent manner without prior 
sensitization, secrete several cytokines, and proliferate in re- 
sponse to IL-2 (1). 
CD16,  a major surface structure on NK cells capable of 
triggering their functional program, is the low-affinity re- 
ceptor for the Fc fragment of lgG (Fc',/ILIIIA) (2, 3).  It ex- 
ists as an oligomeric complex composed of one Fc-binding 
c*  chain  associated  with  homo-  or  heterodimers  of the 
family proteins such as CD3~ and the y  subunit of the high- 
affinity IgE receptor, FcelLI. FcyRIIIA occupancy by either 
immunocomplexes  or  specific  mAb  initiates  a  cascade  of 
biochemical intracellular  signals  including  protein  tyrosine 
phosphorylation (4-9),  phospholipase activation (6,  7,  10), 
inositol triphosphate generation, and intracellular Ca  a+ mo- 
bilization (11). 
Engagement of multimeric  antigen  receptor  complexes 
on T  and B lymphocytes and a number of cytokine recep- 
tors induce activation of the p21 ras signaling pathway (12). 
The conversion of tLas from its inactive GDP-bound state 
to its active GTP-bound state is regulated by the opposite 
effects of proteins that stimulate the  intrinsic  rate of GTP 
hydrolysis  (guanosine  triphosphatase-activating  proteins) 
and proteins that regulate the exchange rate of bound GDP 
for  cytosolic  GTP  (guanine  nucleotide  exchange  factors) 
(13).  One of the exchange proteins involved in 1Las activa- 
tion by a number of receptors is Sos,  a homologue of the 
Drosophila  son  of sevenless gene  product  (14),  which  is  re- 
cruited to the cell membrane by the adaptor protein Grb2/ 
Sem-5. Grb2, a 23-kD protein, comprises two Src homol- 
ogy (SH) I 3  domains that bind the COOH-terminal pro- 
line-rich  domain  of Sos and  a  SH2  domain  that  interacts 
with tyrosine phosphoproteins (15,  16).  Shc is one of sev- 
eral substrates of protein tyrosine kinases (PTKs) interacting 
with Grh2.  Shc exists in three isoforms of 46,  52,  and 66 
kD  (only  the  former two  are  expressed  by  hemopoietic 
cells)  and is composed of a single SH2 domain, a glycine/ 
proline-rich  collagen  homology  domain,  and  a  unique 
NH2-terminal domain (designated N) (17).  It functions as a 
1Abbreviations used in this paper: GAM, goat ann-mouse lgG; GST, glu- 
tathione S-transferase; PTK, protein tyrosine kinase; SH, Src homology. 
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receptors either endowed with tyros,he kinase activity (18- 
20)  or capable of activating nonreceptor tyrosine kinase(s) 
(21-27).  Phosphorylated  Shc  interacts with  Grb2,  which, 
in turn, interacts with Sos. In T  and B  cells, antigen recep- 
tor-mediated  P,,as activation  is  associated  with  tyrosine 
phosphorylation of Shc (21-24). However, a 36-kD mem- 
brane-bound phosphoprotein has also been proposed as an 
adaptor that links TCR-activated PTKs to Grb2-Sos con> 
plex (22, 28). 
No information is currently available on the R.as  signal- 
ing pathway in NK cells activated through  CD16  ligation 
or  other  stimuli  including  IL-2,  which  activates  P,as  and 
induces  a  rapid formation of Shc-Grb2-Sos complexes in 
T  cells (25, 26). 
Here we investigated whether the p21 '~ pathway is acti- 
vated in human  NK cells upon CD16  or IL-2 stimulation. 
In particular, we were interested in studying whether Grb2 
complexes might be involved in P,as activation by examin- 
ing the phosphotyrosine proteins associated with Grb2 after 
CD16 or IL-2R triggering. Our results indicate that activa- 
tion of human  NK cells through  CD16  or by IL-2 results 
in a rapid accumulation ofGTP-bound p21 ~a~. CD16-medi- 
ated  tkas  activation  is  accompanied  by  Grb2  association 
with both Shc and p36  tyrosine phosphoproteins, whereas 
only phosphorylated Shc forms a stable complex with Grb2 
upon IL-2 stimulation. 
Materials  and Methods 
Antibodies  and  Reagents.  The  following mouse  ,nAbs  were 
used.  Anti-CD3  (Leu4),  anti-CD16  (Leullc),  and  anti-CD56 
(Leul9) were purchased from Becton Dickinson & Co. (San Jose, 
CA).  Anti-CD16  (B73.1)  mAb was  kindly provided by Dr.  G. 
Trinchieri  (Wistar  Institute,  Philadelphia,  PA).  Anti-CD56 
(C218)  ntAb was generously provided by Dr. A. Moretta (Uni- 
versity of Genoa, Genoa, Italy). Goat F(ab')2 anti-mouse IgG Ab 
(GAM) was  purchased from  Cappel Laboratories (Cooper Bio- 
medical Inc., Malvem, PA). Affinity,-purified rabbit anti-Shc an- 
tiserum used in immunoprecipitation and anti-Grb2 mAb used in 
Western blotting were obtained from Transduction Laboratories 
(Lexington, KY). Anti-Shc mAb was kindly provided by Dr. P. G. 
Pelicci (Universit  T ofPerugia, Perugia, Italy). The polyclonal an- 
tiserum against Grb2 used in imnmnoprecipitation was obtained 
from Santa Cruz Biotechnolob~, (Santa Cruz, CA). The antiphos- 
pho~'rosine (anti-pTyr) mAb 4G10 was purchased from Upstate 
Biotechnology, Inc. (Lake Placid, NY). Y13-259 (anti-Ras) mAb 
was a kind gift of Dr. S.A. Aaronson (The Mount Sinai Medical 
Center,  New York).  Human  rlL-2 was provided by EuroCetus 
B.V.  (Amsterdam, The  Netherlands).  Bacteria expressing either 
the glutathione S-transferase (GST)-Grb2SH2 fusion pro[ein or 
GST alone were kindly provided by Dr. P.G. Pelicci. 
Preparation qf Human  NK  Cells.  NK  cell cultures were  ob- 
tained by coculturing nylon nonadherent  PMBC  (4  ￿  10S/ml) 
with irradiated (3,0(30 rad) ILPMI 8866 cells (105/nil)  for 10 d at 
37~  in a humidified 5~  CO_, atmosphere as previously described 
(29).  On  day  10,  the  cell  population  was  routinely  80-90% 
CD56+CD16+CD3  ,  as  assessed  by  cytofluorimetric  analysis. 
When  purity  was  <90%,  contaminating  T  cells  were  further 
eliminated by panning or by rigorous immunomagnetic negative 
selection with anti-CD5 ntAb. The resulting NK cell population 
was >90% pure. 
Cell  Stimulation  and  Lysate  Preparation.  Highly purified cul- 
tured human NK cells (5  ￿  10V/tube) were incubated with satu- 
rating concentrations ofanti-CD16 (B73.1)  or anti-CD56 (C218) 
mAb for 20  min  on  ice.  After washing off unbound  antibody, 
cells were resuspended in prewamaed R,  PMI medium, and GAM 
F(ab')2 was added at a concentration of 2 p,g/106 cells; IL-2 stim- 
ulation was peffomaed by incubating the cells with 500  IU rlL-2 
in  0.5  ml.  Cells were  lysed (lysis buffer containing  I% vol/vol 
Triton X-100, 50 mM Tris-HC1 [pH 8],  150 mM NaC1,  5 mM 
EGTA [pH 8],  1.5 mM MgC12, 10% glycerol, I00 ~,g/ml PMSF, 
1 Dg/ml aprotinin,  1 p.g/ml leupeptin,  I  Izg/ml pepstatin, 200 
~g/ml Na3VO 4, and 50 mM NaF [pH 8]).  Lysates were cleared 
of debris by centrifugation at 14,000 2 for 20 rain, and the super- 
natants were used for immunoprecipitation and affinity-binding 
experiments. 
lnlmunopprcipitation and  lmmunoblotting.  Cell lysates were  im- 
munoprecipitated with appropriate concentrations of polyclonal 
anti-She or anti-Grb2 antibody and protein A-Sepharose beads 
for 2 h at 4~  The beads were washed four times in a mixture of 
0.1% vol/vol NP-40, 50 mM Tris HCI (pH 8),  150 mM NaCl, 
1 mM  EDTA  (pH  8),  200  ~tg/ml Na3VO4,  separated on  SDS- 
PAGE gels, and transferred to nitrocellulose filters. After blocking 
nonspecific reactivity, filters were probed with specific antibodies 
diluted in  TBS-T  (20  mM  Tris HCl  pH  7.8,  150  mM  NaCI, 
0.02%  Tween 20)  comaining 19/o BSA. After extensive washing, 
inmmnoreactivity was  detected  using an  enhanced  chemilumi- 
nescence kit  (Amersham International plc, Amersham,  UK).  In 
some experiments, blots were stripped with 62.5  mM  Tris-HC1 
(pH 6.8), 2% SDS, and  100 mM [3-ME  at 50~  for 30 rain and 
reprobed. 
In  Vitro Binding Studies Using GST-Grb2SH2  Fusion Protein. 
Recombinant GST or GST-Grb2SH2 fusion protein was  puri- 
fied onto  glutathione Sepharose 4B  (Pharmacia  LKB,  Uppsala, 
Sweden) and used for binding assays. NK cell lysates (31) X  10"/ 
sample)  were incubated for 2 h at 4~  with an appropriate con- 
centration of either GST or GST fusion protein bound to glu- 
tathione  Sepharose  4B.  Protein  complexes  were  washed  eight 
times  in  ice-cold lysis buffer,  eluted,  denatured  by  heating  at 
95~  fbr 3  nfin  in  reducing Laemmli buffer,  and  subjected to 
SDS-PAGE and Western Blot analysis. 
p2I "~  Activation.  p2V  ~' was  inmmnoprecipitated with  Y13- 
259  ,nAb from cells in which guanine nucleotides were biosyn- 
thetically  labeled  with  peP]orthophosphate  as  described  (30). 
Ras-bound labeled guanine nucleotides were eluted, separated by 
TLC. and then quantitated by direct scanning for 13 radiation us- 
ing  a  Phosphorlmager  (Molecular Dynamics,  Sunnyvale,  CA). 
Results are expressed as the percentage of p21 ~  proteins bound to 
GTP relative to total guanine nucleotides complexed to the protein. 
Results 
Site  Proteins  Are  Tyros,he  Phosphorylated  upon  CD16  and 
IL-2R  Stimulation  in  Hunlan  NK  Cells.  CD16  cross-link- 
ing results in the tyrosine phosphorylation of several cellu- 
lar  substrates  (4-9).  To  investigate  whether  Shc  is  phos- 
phorylated on tTrosine residues upon NK cell stimulation, 
cultured  human  NK  cells were  stimulated  with  rlL-2  or 
saturating  concentrations  of anti-CD16  (B73.1)  or  anti- 
CD56  (C218)  mAb  and  cross-linked with  GAM  F(ab')2 
fragments  for  the  indicated  times  at  37~  Shc  proteins 
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clonal  anti-Shc  antiserum,  and  Shc  immunoprecipitates 
were analyzed for the presence oftyrosine phosphoproteins 
by  immunoblotting  with  an  antiphosphotyrosine  (anti- 
pTyr)  mAb.  Marked tyrosine phosphorylation of both the 
46-  and  52-kD  isoforms of Shc  was  detected  after  CD16 
cross-linking (Fig.  1 B). CD16-mediated  Shc phosphoryla- 
tion was rapid, with a peak at 1 min and a decline at 5 rain. 
IL-2  also  stimulated  a  rapid  tyrosine  phosphorylation  of 
both p46 and p52 isoforms of Shc, but unlike CD16, phos- 
phorylation was still  observed 10 min after stimulation.  No 
changes in the phosphorylation status of Shc were observed 
in NK cells treated with  anti-CD56  mAb used as control. 
After stripping  off bound  antibodies,  the  same  membrane 
was incubated with anti-Shc mAb to verify that an equiva- 
lent amount of Shc proteins was present in all lanes.  Sam- 
ples  stimulated  with  anti-CD16  mAb  or  IL-2  showed  a 
small shift of both Shc isoforms to a lower electrophoretic 
mobility due to induced phosphorylation (Fig. 1 D). 
Figure 1.  CD16 and IL-2R stimulation induce the tyrosine phosphory- 
lation of Shc and its association with Grb2 and a 145-kD tyrosine phos- 
phoprotein: time course. Cultured NK cells were stimulated with control 
medium or appropriate doses ofrlL-2, anti-CD16 (B73.1), or anti-CD56 
(C218) mAb for the indicated times at 37~  Cell lysates (50 ￿  106 cells/ 
sample) were subjected to immunoprecipitation with polyclonal  anti-Shc 
or preimmune serum (NRS). Resulting protein complexes were resolved 
by  10%  SDS-PAGE, transferred to nitrocellulose, and immunoblotted 
with either anti-pTyr (A and B), anti-Grb2 (C), or anti-Shc (D) antibod- 
ies. All panels are from the same experiment and from different regions of 
the same blot. In A, the arrowhead indicates the IL-2R~ chain. IgH de- 
notes the heavy  chain of the precipitating Ab. Sizes are indicated in kilo- 
daltons. These results are representative of one out of three independent 
experiments. 
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Interestingly,  an  additional  unidentified  tyrosine-phos- 
phorylated  protein  of "-'145  kD  consistently  coimmuno- 
precipitated with Shc from CD16- or IL-2-stimulated NK 
cells lysates; tyrosine phosphorylation of Shc and p145 oc- 
curred with the same kinetics (Fig.  1 A). The band migrat- 
ing at ~70  kD in the immunoprecipitates  from IL-2-acti- 
vated NK cell lysates likely corresponds to IL-2R]3 chain, 
as previously reported (26); the background band migrating 
at 46 kD is the IgH chain of the antibody used for immu- 
noprecipitation. 
In light of the evidence showing that the SH2 domain- 
containing adaptor protein Grb2 binds tyrosine-phosphory- 
lated Shc (15,  18), we then investigated whether this com- 
plex is also formed in activated NK cells.  CD16 or IL-2R 
triggering of NK cells resulted in  Grb2-Shc association,  as 
shown by immunoblotting of Shc precipitates with an anti- 
Grb2 antibody (Fig.  1 C). 
These  observations  indicate  that  NK  cell  stimulation 
through  CD16  and  IL-2R induces  tyrosine  phosphoryla- 
tion of Shc and its association with Grb2. 
A  36-kD Tyrosine Phosphoprotein Coimmunoprecipitates with 
Grb2 in CD16-stimulated  NK Cells.  Immunoprecipitation 
of Grb2 from cell lysates of untreated, anti-CD16-, or IL-2- 
stimulated NK cells  was performed to visualize the interac- 
tions  between  Grb2  and  molecules  that  become  tyrosine 
phosphorylated after NK  cell activation.  Associated mole- 
cules were separated by SDS-PAGE, blotted on nitrocellu- 
lose filters,  and probed with  anti-pTyr mAb. As shown in 
the upper portion of Fig.  2,  Grb2 coimmunoprecipitates  a 
strongly tyrosine-phosphorylated protein of,--~36 kD in ly- 
sates of CD 16- but not IL-2-stimulated NK cells.  Tyrosine 
phosphorylation  of the  36-kD  protein  and  its  association 
with Grb2 occurred very rapidly, peaking at 1 rain and de- 
creasing significantly at 5  min after  CD16 ligation.  As ex- 
pected,  Grb2  immunoprecipitates  of stimulated  NK  cells 
also contained the 46- and 52-kD  isoforms of phosphory- 
lated  Shc  as  identified  by  anti-Shc  immunoblotting  (data 
not shown). The faint band migrating at ~46 kD, observed 
in the unstimulated sample, was not reactive with anti-Shc 
antibody,  suggesting that  it was  the  IgH of the  immuno- 
precipitating  antibody.  The  anti-CD56-treated  sample  is 
comparable to the untreated sample (not shown). Immuno- 
blot  of Grb2  immunoprecipitates  with  an  anti-Grb2  anti- 
body shows that an equivalent amount of Grb2 was present 
in all lanes (Fig. 2, bottom). 
To  establish  whether  the  p36  phosphoprotein  detected 
in  the  Grb2  complex was directly bound to  Grb2,  we at- 
tempted  to  immunodeplete  Shc  and  determine  whether 
p36  was still  associated  with  Grb2  under  these  conditions 
(Fig.  3).  After complete depletion  of Shc from cell lysates, 
the  intensity  of tyrosine-phosphorylated  p36  protein  in 
anti-Grb2  immunoprecipitates  was  unaffected,  suggesting 
that p36 directly interacts with Grb2. 
The SH2 Domain of Grb2 Complexes with p36 or Shc Ty- 
rosine Phosphoproteins.  The Grb2 molecule binds to several 
phosphotyrosine-containing  proteins  via  the  SH2  domain 
(15,  16,  18).  Moreover,  a  36-kD  tyrosine-phosphorylated 
protein  has been  reported  to  complex with  the  Grb2SH2 Figure 2.  Analysis  of phosphotyrosine  proteins in the immunoprecipi- 
tates of Grb2  after CD16 or IL-2R. stimulation.  Lysates from 50  ￿  106 
cultured  NK cells stimulated  with control medium or appropriate  con- 
centrations of rlL-2 or anti-CD 16 (B73.1) mAb for the indicated times at 
37~  were immunoprecipitated  with polyclonal anti-Grb2  antibody. R_e- 
sulting protein complexes were resolved by 10% SDS-PAGE,  transferred 
to nitrocellulose,  and immunoblotted with either anti-pTyr (upper  panel) 
or anti-Grb2  (lower  panel). The panels are from the same experiment and 
from different regions of the same blot. Shc bands were identified by re- 
probing  the blot with anti-Shc antibody  (data not shown).  Sizes are indi- 
cated in kilodaltons.  These  results are representative  of one out of three 
independent  experiments. 
domain in TCR-activated T  cells (22,  28).  To test whether 
the interaction  of p36  and  Shc phosphoproteins  with Grb2 
is  mediated  through  the  SH2  domain,  lysates  from  un- 
treated,  CD56-,  CD16-  or IL-2-stimulated  NK  cells were 
incubated  with  a  bacterially  expressed  Grb2SH2  fusion 
protein immobilized on glutathione-agarose  beads,  and the 
bound  phosphotyrosine  proteins  were  analyzed.  The  re- 
sults,  shown  in  Fig.  4,  indicate  that  the  SH2  domain  of 
Grb2  in vitro binds  both  tyrosine-phosphorylated  Shc  and 
p36 in CD16-stimulated  NK  cells and only phosphorylated 
Shc  in  IL-2-stimulated  NK  cells.  The  control  GST  alone 
failed to precipitate any tyrosine-phosphorylated  proteins. 
These  results  indicate  that  the  association  between  ty- 
rosine-phosphorylated  p36  or  Shc  and  the  adaptor  mole- 
cule Grb2  occurs via the interaction with the SH2 domain 
of Grb2. 
CD16 and IL-2R  Triggering Activate p21TM in Human  NK 
Cells.  Grb2  complexes  containing  a  p36  phosphoprotein 
or phosphorylated  Shc have been implicated in the activa- 
tion  of  the  p21TM guanine  nucleotide-binding  cycle  in 
TCR-  (28)  or IL-2-stimulated  human  T  cells (25,  26).  To 
determine whether p21 ra~ is activated upon CD16 or IL-2R. 
triggering  in  NK  cells,  p21raVGTP  loading  experiments 
were performed.  NK  cells were exposed to anti-CD 16 and 
anti-CD56  mAbs,  IL-2,  or the phorbol  ester PMA,  which 
has been shown to activate P,  as in a PKC-dependent  man- 
Figure  3.  36-kD  tyrosine-phosphorylated  protein  interacts  directly 
with Grb2.  Cultured NK cells were stimulated with control  medium or 
appropriate  doses of rlL-2  and  anti-CD16  (B73.1)  mAb  for 2  min  at 
37~  Cell lysates (50 ￿  106 cells/sample) were, when indicated, depleted 
of Shc proteins  by two subsequent  cycles of immunoprecipitation  with 
anti-Shc  antibody  and  immunoprecipitated  with anti-Grb2  antibody  or 
normal  rabbit  serum  (NRS).  Immunoprecipitates  were subjected  to  8% 
SDS-PAGE,  transferred to nitrocellulose,  and blotted with anti-pTyr an- 
tibody.  IgH denotes the heavy chain of the precipitating Ab. Sizes are in- 
dicated in kilodaltons. These  results are representative  of one out of two 
independent  experiments. 
ner  in  T  lymphocytes  (30).  [32p]Orthophosphate-loaded 
cells  were  lysed  and  p21 raS  was  immunoprecipitated.  The 
proportion  ofp21ra<bound  GTP,  expressed as the ratio be- 
tween  GTP  and  GTP  plus  GDP  on p21 r~,  was  evaluated 
by emission scanning of TLC-resolved guanine nucleotides 
eluted  from  p21 ~"~  immunoprecipitates.  Fig.  5  shows  that 
Figure 4.  In vitro association of the 36-kD and Shc tyrosine phospho- 
proteins  with the SH2 domain of Grb2.  Cultured NK cells were stimu- 
lated  with  control  medium  or  appropriate  doses of IL-2,  anti-CD16 
(B73.1), or anti-CD56 (C218) mAbs for 2 min at 37~  Cell lysates (30 X 
106 cells/sample) were incubated  with GST alone or GST-Grb2SH2 fu- 
sion protein bound to glutathione-agarose  beads. The resulting protein 
complexes  were resolved  by 8% SDS-PAGE and  immunoblotted with 
anti-pTyr antibody (upper  panel). The blot was stripped and reprobed with 
anti-Shc antibody  (bottom panel). Sizes are indicated  in kilodaltons. These 
results are representative of one out of four independent  experiments. 
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2R.  TLC  of the nucleotides eluted from p21  ~  immunoprecipitates of 
[32p]orthophosphate-labeled NK cells (upper panel).  Cells were stimulated 
for the indicated times with appropriate doses of anti-CD56 (C218) and 
anti-CD16 (B73.1) mAbs, rlL-2, or PMA (100 ng/ml) before lysis and 
immunoprecipitation of  p21 r= with Y13-259 mAb as described (30). The 
position at which GTP and GTP standards run is indicated. The lower 
panel shows the data derived from quantitation by direct scanning for 13 
radiation of the same experiment. C218 (open  circles), B73.1 (solid  circles), 
PMA (open  squares),  IL-2 (solid squares).  These results are representative of 
one out of  three independent experiments. 
CD16 triggering results  in a  threefold increase  in the pro- 
portion  of GTP-bound P.as  (from 5  to  17%),  an  increase 
similar  to  that  observed  after  IL-2 stimulation.  PMA also 
resulted  in  accumulation  of GTP-bound  Ras,  suggesting 
that p21 ras can be activated in NK cells via a PKC-depen- 
dent pathway. 
The time course of CD16- Or IL-2-mediated p21 ras acti- 
vation  strictly paralleled  the induction  of Shc and p36  ty- 
rosine phosphorylation and Grb2-containing complex for- 
mation; upon CD16 cross-linking, 1kas activation peaked at 
1 rain and returned to basal levels within 5 min, whereas it 
persisted  until  10  min  after  IL-21L stimulation.  The  anti- 
CD56  control  mAb-treated  sample  shows  a  p21 r~s  GTP/ 
GDP+GTP  ratio  comparable to the untreated sample (not 
shown). 
Discussion 
Many  recent  studies  have  indicated  the  SH2/SH3  do- 
main-containing protein Grb2 in the coupling of PTK ac- 
tivation with the 1Kas signaling pathway in mammalian cells 
(15). In this study, we investigated the possible role of Grb2 
in  CD16- and IL-2R-mediated activation of p21 ~"~ in hu- 
man  NK  cells.  Our findings  show that  CD16  ligation  re- 
suits  in  a  rapid  tyrosine  phosphorylation  of both  p46  and 
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p52 isoforms of the Shc protein.  IL-2R stimulation also in- 
duces  Shc  phosphorylation in  NK  cells,  as  previously de- 
scribed  for T  cells  (25,  26).  IL-2-induced  tyrosine  phos- 
phorylation  of Shc  occurs  at  levels  comparable  to  those 
observed upon CD16  ligation,  although  it is  more persis- 
tent,  remaining at about the same levels  10 rain after cyto- 
kine stimulation. 
Shc tyrosine phosphorylation correlates with the forma- 
tion of complexes containing Grb2 and an unidentified  ty- 
rosine-phosphorylated protein of 145 kD. Phosphoproteins 
of a similar molecular mass  (pp145)  have been reported to 
associate with Shc in T, B, and myeloid cells in response to 
several stimuli  (21, 24, 27). The binding domain for pp145 
(designated PTB domain)  has recently been mapped in the 
NH2 terminus of the Shc protein (31). 
In contrast to the rapid Shc phosphorylation observed in 
CD16-stimulated  NK cells,  TC1L stimulation  by itself in- 
duces only low levels of Shc tyrosine phosphorylation and 
Grb2  association,  and  CD4  coengagement  is  required  to 
potentiate  Shc  phosphorylation  (21).  Similarly,  BCR- 
induced  Shc  tyrosine  phosphorylation  is  markedly  en- 
hanced  by CD19  receptor  coligation  in B  cells  (32).  The 
molecular basis  of this  phenomenon  is  still  poorly under- 
stood. It is possible that CD4 and CD19, which are physi- 
cally and functionally coupled to Src-family PTKs (33-35), 
might  augment  Shc  tyrosine  phosphorylation  elicited  by 
the  antigen  receptors  by  recruiting  Src-family  kinases  in 
their proximity.  Several lines of evidence indicate that Shc 
may be a good substrate for Src-family PTKs: first,  p561ok is 
detected  in  Shc immunoprecipitates  after  CD4  cross-link- 
ing  (36)  and  phosphorylates  Shc  fusion  protein  in  vitro 
(37); second, Src SH3 domain binds to the proline-rich do- 
main  of Shc  (38);  and  finally,  Shc  is  constitutively  phos- 
phorylated on tyrosine residues in cells expressing v-Src or 
v-Fps and forms a  complex with  Grb2  (39).  It is conceiv- 
able, therefore,  that the lack of requirement for coreceptor 
engagement  in  the  stimulation  of  Shc  phosphorylation 
upon CD16 and IL-21L ligation may be attributable  to the 
constitutive coupling of these receptors to Lck (40, 41). 
In addition to Shc, we detected a major 36-kD tyrosine- 
phosphorylated protein interacting with Grb2 upon CD16 
stimulation.  The  interaction  between  p36  and  Grb2  oc- 
curred very rapidly after CD16 stimulation with  a kinetics 
similar to that of Grb2-Shc association, p36-Grb2 complex 
formation appears to be receptor specific, as it was not de- 
tected in  IL-2-stimulated  NK  cells.  Furthermore,  interac- 
tion between Grb2 and p36 or Shc phosphoproteins is me- 
diated  through  the  SH2  domain  of  Grb2  and  is  likely 
induced  by  Shc  and  p36  phosphorylation.  As  individual 
SH2  domains  interact with  only one binding pattern,  our 
results suggest that two populations of Grb2 exist in CD16- 
stimulated  NK  cells,  one  that  is  complexed with  Shc and 
the other with p36. 
Recent reports (22, 28) describe a membrane-bound 36- 
kD phosphoprotein that binds to the SH2 domain of Grb2 
in  TCR-stimulated  T  cells  that  appears  to  be  identical  to 
the  36-kD  phosphoprotein  described  here.  p36  is  one  of 
the major PTK substrates  in T  cells  and may also associate with the SH2 domain of PLC-y (22,  42).  No evidence of 
p36  tyrosine phosphorylation or association with Grb2 has 
been found in B  lymphocytes upon BCR  stimulation  (23, 
24,  32).  In view of the  possible  common origin of T  and 
NK  cells  (43,  44),  it  would  be  of interest  to  investigate 
whether p36 expression or its wrosine phosphorylation and 
consequent Grb2 association  is restricted  to these  two lin- 
eages. 
These results also show that both CD16 ligation and IL- 
2R stimulation induce a rapid accumulation of p21 .... GTP 
complexes in human NK cells.  The kinetics of Ras activa- 
tion  strictly  parallel  that  of She  and  p36  phosphorylation 
and  Grb2  association  observed  upon  CD16  and  IL-2R 
triggering.  The role of Grb2  in p21 r~ activation is further 
supported by the finding of Grb2-Sos complex in NK cells 
(data not shown). 
Taken  together,  our  results  indicate  that  two  different 
mechanisms  might  couple  CD16  to  the  Ras  pathway  in 
NK cells:  phosphoDqation  of Shc,  which  has been  impli- 
cated  in both  receptor  Wrosine  kinase-  and  non-receptor 
tyrosine  kinase-induced  Ras  activation  (18-20,  25,  26), 
and p36, which has been proposed to be involved in TCR- 
mediated  p2V  a~ activation  (22,  28).  It is possible  that  She 
and  p36  represent  additive  complementary  pathways  that 
couple  CD16  to  p21 r~.  On  the  other  hand,  one  of these 
pathways could be dominant and the other redundant.  The 
existence  of more than one Grb2-Sos complex potentially 
involved in  p2V~-GTP  formation  has  been  described  for 
several growth factor receptors, including EGFR and insu- 
lin receptor.  For these receptors,  She has been found to be 
the major molecular connection between the receptor and 
the  Grb2-Sos-p2V  ~  signaling  cascade  (45,  46).  To  better 
understand  the  relative  role  of Shc-Grb2-Sos  and  p36- 
Grb2-Sos  complexes  in mediating  the  CD16-induced  in- 
crease  in cellular p21r~-GTP,  a further characterization  of 
p36 is required. 
The  function  of p21 ra-~ in  NK  cells  remains  unclear. 
Cross-linking of both CD16 and IL-2R delivers intracellu- 
lar signals  that trigger the functional program of NK cells. 
Stimulation of NK ceils through CD16 or by IL-2 promotes 
expression of genes encoding for cytokines such as IFN-y, 
TNF-ot, GM-CSF, or activation markers including IL-2Rci 
chain and CD69 (11, 47, 48). In addition,  IL-2 is the major 
cytokine capable of sustaining NK cell growth (1). 
The  role  of p21 r~  in downstream  biologic  responses  to 
ligand has been addressed in several systems. Several lines of 
evidence  suggest  that  p2V  ~  acts  ubiquitously  in  signal 
transduction  pathways leading  to cellular proliferation  and 
differentiation  (49,  50).  The  transmission  of signals  from 
p2V  ~"  to  the  nucleus  involves  the  activation  of mitogen- 
activated  protein  kinases  as  the  extracellular  signal-regu- 
lated (ERKs) andJun kinases, which have several transcrip- 
tional factors as main targets (51). 
In T  lymphocytes,  a  role  of p21 r~  in  the  regulation  of 
IL-2  gene  and  CD69  expression  has  been  demonstrated 
(52,  53).  Ras  regulation  of other  cytokine  genes  has  also 
been proposed (54).  Preliminary results indicate that CD 16 
ligation induces activation of p42 and p44 ERK in human 
NK cells  (Gismondi,  A.,  and A.  Santoni,  unpublished  ob- 
servations).  It  is  conceivable,  therefore,  that  p21 r~  activa- 
tion  induced  upon  IL-2R and  CD16  stimulation  on  NK 
cells  plays a major role in the control of their proliferation 
and functions. 
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